Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).

MLA

Merlano, Marco Carlo, et al. “Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).” Oncology, vol. 98, no. 11, 2020, pp. 763–70. EBSCOhost, https://doi.org/10.1159/000507733.

APA

Merlano, M. C., Denaro, N., Vecchio, S., Licitra, L., Curcio, P., Benasso, M., Bagicalupo, A., Numico, G., Russi, E., Corvo’, R., & Bruzzi, P. (2020). Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700). Oncology, 98(11), 763–770. https://doi.org/10.1159/000507733

Chicago

Merlano, Marco Carlo, Nerina Denaro, Stefania Vecchio, Lisa Licitra, Paola Curcio, Marco Benasso, Almalina Bagicalupo, et al. 2020. “Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).” Oncology 98 (11): 763–70. doi:10.1159/000507733.